Bioptik Technology Incorporation
4161
Rank in Stocks
#23903
Bioptik Technology Incorporation operates as a global entity, focusing on the... Bioptik Technology Incorporation operates as a global entity, focusing on the creation and distribution of medical instruments and diagnostic chemicals. The company's product line encompasses the EasyMate series of blood glucose monitoring systems, as well as comprehensive diagnostic devices designed to measure blood glucose, cholesterol, and uric acid levels, complete with their essential test strips. Beyond its healthcare offerings, Bioptik also provides a range of skincare solutions, including those formulated with hyaluronic acid, alongside various dietary supplements. Uniquely, the company diversifies its business by supplying biodiesel products. Founded in 1999, Bioptik Technology Incorporation is headquartered in Zhunan, Taiwan.
Share Price
$0.6310283
Last synced: 2026-11-10
Market Cap
$37.73M
Change (1 day)
0.24%
Change (1 year)
-25.07%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Bioptik Technology Incorporation (4161)
Category
Healthcare
EPS for Bioptik Technology Incorporation (4161)
EPS as of June 2026 TTM: $0.06
According to Bioptik Technology Incorporation's latest financial reports, its current EPS (TTM) is $0.06. At the end of 2025 the company had an EPS of $0.04, a decrease compared to its 2024 EPS of $0.06.
EPS history for Bioptik Technology Incorporation from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.06 | 43.50% |
| 2025 | $0.04 | -30.12% |
| 2024 | $0.06 | 2.37% |
| 2023 | $0.05 | 68.10% |
| 2022 | $0.03 | 101.23% |
| 2021 | $0.02 | -138.57% |
| 2020 | $-0.04 | -1,372.73% |
| 2019 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $2.70 | 4,603.83% |
US
|
|
| $4.09 | 7,025.44% |
IE
|
|
| $9.45 | 16,363.41% |
US
|
|
| $2.37 | 4,028.92% |
US
|
|
| $1.77 | 2,983.62% |
US
|
Questions about Bioptik Technology Incorporation's earnings per share (EPS)
What is Bioptik Technology Incorporation's earnings per share (EPS)?
Bioptik Technology Incorporation's earnings per share (EPS) over the last twelve months is $0.06, as of Jun 2026.
What was Bioptik Technology Incorporation's earnings per share (EPS) in 2025?
In 2025, Bioptik Technology Incorporation's earnings per share (EPS) was $0.04, 33.33% less than in 2024 ($0.06).
How has Bioptik Technology Incorporation's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Bioptik Technology Incorporation's earnings per share (EPS) was highest in 2024 ($0.06) and lowest in 2020 ($-0.04).
How does Bioptik Technology Incorporation's earnings per share (EPS) compare with similar companies?
Bioptik Technology Incorporation's earnings per share (EPS) ($0.06) is lower than that of all 5 similar companies listed above. The highest among them is Stryker Corporation, with $9.45.